Literature DB >> 3419323

Changes in serum lipoprotein pattern induced by acute infections.

K Sammalkorpi1, V Valtonen, Y Kerttula, E Nikkilä, M R Taskinen.   

Abstract

To study the effects of acute infections on serum lipids and lipoproteins we measured the concentration and composition of different lipoproteins, apoproteins A-I, A-II, and B, and the activities of plasma postheparin lipolytic enzymes, lipoprotein lipase (LPL) and hepatic lipase (HL) during acute and convalescence phase and after complete recovery in 72 infectious patients (33 with viral infection and 39 with bacterial infection). The mass concentrations of both low density lipoprotein (LDL) (P less than .001) and high density lipoprotein (HDL)2 (P less than .002) were reduced during acute infections due to the lowering of their cholesterol, phospholipid, and protein contents. The reduction of LDL cholesterol was maximal at the acute stage of infection (change -15%, P less than .001) while the reduction of HDL2 cholesterol was maximal during the convalescence (change -35%, P less than .001). During acute infections LDL became triglyceride-enriched (11.8 v 8.6%, P less than .0001) but cholesterol-poor (36.6 v 39.3%, P less than .0001). The ratio of HDL cholesterol/LDL cholesterol was significantly reduced during the convalescence (0.42 +/- 0.15 v 0.53 +/- 0.19, P less than .0001). The concentrations of apo A-I and apo A-II were decreased during acute infections (changes -22%, P less than .001, and -16%, P less than .001, respectively). The very low density lipoprotein (VLDL) was 18% higher during the convalescence period than after the recovery due to the elevations of VLDL triglycerides, cholesterol, and phospholipids. The activity of LPL was reduced both in the acute and convalescence phase, whereas that of HL was reduced only in the acute phase of infections.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3419323     DOI: 10.1016/0026-0495(88)90120-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  56 in total

1.  Serum total cholesterol in nosocomial infections after gastrointestinal surgery.

Authors:  Mitsuaki Morimoto; Yosikazu Nakamura; Sadakane Atsuko; Takashi Nagaie; Ken Shirabe
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?

Authors:  S Niemelä; T Karttunen; T Korhonen; E Läärä; R Karttunen; M Ikäheimo; Y A Kesäniemi
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

3.  Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.

Authors:  Min Sun Kim; Trevor R Sweeney; Judy K Shigenaga; Lisa G Chui; Arthur Moser; Carl Grunfeld; Kenneth R Feingold
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

Review 4.  LOX-1, a new marker of risk and prognosis in coronary artery disease?

Authors:  Valter Lubrano; Silvana Balzan
Journal:  Mol Cell Biochem       Date:  2013-08-11       Impact factor: 3.396

5.  Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3.

Authors:  Marta Biedzka-Sarek; Jari Metso; Andreas Kateifides; Taru Meri; T Sakari Jokiranta; Artur Muszyński; Joanna Radziejewska-Lebrecht; Vassilis Zannis; Mikael Skurnik; Matti Jauhiainen
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

6.  The modulation of plasma lipids and lipoproteins during bone marrow transplantation is unrelated to exogenously administered recombinant human granulocyte-monocyte colony-stimulating factor (rHu GM-CSF).

Authors:  E J Dann; Y Friedlander; E Leitersdorf; A Nagler
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

7.  Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon.

Authors:  Benjamin J Visser; Sophia G de Vries; Rieke Vingerling; Martin Gritter; Danielle Kroon; Lídia Ciudad Aguilar; Rik B J Kraan; Rosanne W Wieten; François Danion; Barbara Sjouke; Akim A Adegnika; Selidji T Agnandji; Peter G Kremsner; Thomas Hänscheid; Petra F Mens; Michèle van Vugt; Martin P Grobusch
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

Review 8.  Treating low high-density lipoprotein cholesterol: what is the evidence?

Authors:  Mirella P Hage; Sami T Azar
Journal:  Ther Adv Endocrinol Metab       Date:  2014-02       Impact factor: 3.565

9.  Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.

Authors:  I Hardardóttir; A H Moser; J Fuller; C Fielding; K Feingold; C Grünfeld
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Ja-Hyun Hong; Hyung-Shin Lee; Joon-Sung Lee; Kyung-Tai Whang
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.